Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APAF1 | O14727 | 1/20 | 0.56 |
| ▸ | MME | P08473 | 8/20 | 0.51 |
| ▸ | CASR | P41180 | 1/20 | 0.46 |
| ▸ | ACP3 | P15309 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9752562 | 1.00 | APAF1 (0.56) | APAF1MMECASRACP3MEN1 | |
| SCHEMBL7944349 | 1.00 | APAF1 (0.56) | APAF1MMECASRACP3MEN1 | |
| Hydrochloric Acid SCHEMBL27713537 | 0.98 | APAF1 (0.54) | APAF1MMECASRACP3MEN1 | |
| SCHEMBL27505417 | 0.87 | APAF1 (0.53) | APAF1MMECASRACP3MEN1 | |
| SCHEMBL652495 | 0.84 | MEN1 (0.56) | APAF1MMECASRACP3MEN1 | |
| SCHEMBL17530041 | 0.83 | MMP9 (0.55) | APAF1MME | |
| SCHEMBL18722285 | 0.83 | MMP9 (0.55) | APAF1MME | |
| SCHEMBL17530042 | 0.83 | MMP9 (0.55) | APAF1MME | |
| SCHEMBL11774297 | 0.83 | APAF1 (0.51) | APAF1CASRACP3MEN1KMT2A | |
| SCHEMBL14935643 | 0.82 | MME (0.47) | APAF1MMEKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020177551-A1 | Compositions and methods for treatment of neoplastic disease | TERMAN DAVID S (US) | 2002-11-28 | — | — | US | disclosed |
| US-6322964-B1 | PEPTIDE FOR USE AS A DIAGNOSTIC TOOL IN DETECTION OF PREFERENTIAL VIRAL DISEASE | GENETIC SYSTEMS CORPORATION | 2001-11-27 | — | — | US | disclosed |
| EP-0284383-B2 | Synthetic antigens for the detection of aids-related disease caused by LAV-2 | GENETIC SYSTEMS CORP (US) | 2000-04-05 | — | — | EP | disclosed |
| US-5166050-A | Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections | BRISTOL-MYERS SQUIBB COMPANY (US) | 1992-11-24 | — | — | US | disclosed |
| EP-0284383-A1 | Synthetic antigens for the detection of aids-related disease caused by LAV-2 | GENETIC SYSTEMS CORPORATION (US) | 1988-09-28 | — | — | EP | disclosed |